GenesisM’s enhanced core platform is designed to provide long-term operational flexibility and accelerate buildout timeline.

In multiple experiments, C-a16 lipids, which contain a phenol group, outperformed LNPs used in currently available mRNA ...

David Baker’s lab has successfully designed binders to disordered proteins, expanding therapeutic access to over 50% of the human proteome.

Three years after spinning out from the University of Glasgow, Chemify has opened its first fully automated facility that marries chemistry, AI, computation, and robotics near the school in the city’s ...

Using machine learning, OmicsTweezer merges diverse data by using deep learning combined with optimal transport.

Sarepta Therapeutics said it will eliminate 36% of its workforce—approximately 500 jobs—in a restructuring that follows the ...

Study insights could improve current understanding of neurodegenerative diseases as well as interpretations of brain scans.

Eight babies, born following Mitochondrial Donation treatment to reduce transmission of mitochondrial DNA disease, show no ...

ImP administration to mouse model induced atherosclerosis without altering the lipid profile, and was associated with immune ...

Single-cell genomics has unlocked new frontiers in understanding cell types in the brain and targeting them with therapies.

The concept of using proteins and other secreted factors to treat heart attack, rather than replacement cells, has emerged.

This next iteration of AI is poised to transform biomanufacturing by overcoming challenges that, today, are insurmountable.